Endo International PLC (NASDAQ:ENDP)

4.72
Delayed Data
As of 4:14pm ET
 +0.165 / +3.62%
Today’s Change
1.94
Today|||52-Week Range
10.89
-34.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.1B

Company Description

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment conducts certain manufacturing, quality assurance, R&D and administration functions. The Generic Pharmaceuticals segment conducts certain manufacturing, distribution, quality assurance and administration functions, as well as certain R&D functions. The International Pharmaceuticals segment's operations are currently conducted through Paladin's leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.

Contact Information

Endo International Plc
Minerva House
Dublin Dublin 4
P:(531) 268-2000
Investor Relations:
(845) 364-4833

Employees

Shareholders

Other institutional41.45%
Mutual fund holders40.40%
Individual stakeholders2.14%

Top Executives

Blaise A ColemanPresident, Chief Executive Officer & Director
Robert PolkeGlobal Head-Operations
Mark BradleyChief Financial Officer & Executive Vice President
Ruth ThorpeChief Information Officer
Susan WilliamsonChief Compliance Officer & Senior Vice President